Firms
Theme

FNB

F.N.B. Corp · NYSE

News

7 latest

Zacks Investment Research

Why F.N.B. (FNB) is a Top Momentum Stock for the Long-Term

F.N.B. Corporation (FNB), a Pittsburgh-based financial holding company, is featured as a stock to watch with a #3 (Hold) Zacks Rank and a B VGM Score. The stock has demonstrated strong momentum with an A Momentum Style Score and 0.2% gains over the past four weeks. One analyst revised earnings estimates upward for fiscal 2026, with the Zacks Consensus Estimate increasing to $1.70 per share, and the company maintains a solid +5.5% average earnings surprise.

Zacks Investment Research

F.N.B. (FNB) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

F.N.B. reported Q3 2026 revenue of $469.12 million, up 2.6% year-over-year but missing Wall Street's estimate of $475.89 million by 1.42%. EPS matched expectations at $0.43.

Zacks Investment Research

F.N.B. (FNB) Q3 Earnings Meet Estimates

F.N.B. Corporation reported Q3 2026 earnings of $0.43 per share, matching consensus estimates but missing revenue expectations by 1.42% at $469.12 million. The stock has underperformed the S&P 500 year-to-date, gaining only 0.8% versus the market's 11.9%.

Zacks Investment Research

Chemung Financial (CHMG) Earnings Expected to Grow: Should You Buy?

Chemung Financial (CHMG) and F.N.B. (FNB) are set to report Q3 2026 earnings with expected year-over-year growth. However, both stocks show negative Earnings ESP readings, making earnings beats unlikely despite their Zacks Rank #3 (Hold) ratings. Chemung Financial has a stronger historical track record of beating estimates.

Zacks Investment Research

F.N.B. (FNB) Earnings Expected to Grow: Should You Buy?

F.N.B. Corporation is expected to report Q3 2026 earnings of $0.43 per share with 4.9% year-over-year growth on October 19. However, a negative Earnings ESP of -0.39% combined with a Zacks Rank #3 makes it difficult to predict an earnings beat. Similarly, Regions Financial faces headwinds with a -0.54% Earnings ESP despite a Zacks Rank #3, making both stocks uncertain candidates for positive earnings surprises.

Zacks Investment Research

F.N.B. (FNB) is a Top-Ranked Value Stock: Should You Buy?

F.N.B. Corporation, a Pittsburgh-based financial holding company, receives a #3 (Hold) rating from Zacks with a VGM Score of B. The stock features attractive valuation metrics including a forward P/E ratio of 10.19, making it appealing to value investors. One analyst revised earnings estimates upward in the last 60 days, with the Zacks Consensus Estimate increasing to $1.70 per share for fiscal 2026.

Mentions FNB

Zacks Investment Research

Will Bluevine Deal Strengthen Valley National's Growth Outlook?

Valley National Bancorp (VLY) announced a $340 million acquisition of Bluevine, a digital small-business banking platform, expected to close in early 2027. The deal will add 175,000 customers and $2.1 billion in core deposits, with management projecting over 8% EPS accretion in 2028 and $50 million in annual cost savings. The acquisition complements VLY's broader strategy to improve its funding mix and accelerate digital transformation.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $FNB · 0 threads

Sign in to post on $FNB

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev